MetaCap

DBV Technologies S.A. (DBVT) vs Valneva (VALN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

DBV Technologies S.A. is the larger company by market cap ($614.0 million vs $556.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

DBVT versus VALN key metrics
MetricDBVTVALN
Share price$9.77$5.87
Market cap$614.03M$556.61M
1-day change-2.10%+0.17%
YTD return—-33.45%
1-year return—-44.88%
5-year return—-79.07%
Forward P/E—4.93
EPS (TTM)$-3.50$-2.10
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$26.19$12.18
52-week low$9.64$4.75
Distance from 52-week high-62.69%-51.81%
Average volume325.32K77.94K
Shares outstanding62.85M94.82M
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

DBVT vs VALN FAQ

Which is bigger, DBV Technologies S.A. or Valneva?

DBV Technologies S.A. (DBVT) is larger, with a market capitalization of $614.03M compared with $556.61M for Valneva (VALN).

Are DBV Technologies S.A. and Valneva in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons